ClinicalTrials.Veeva

Menu

Prospective PRO/QoL Registry for Patients With Bone Metastases of Breast or Prostate Cancer (PROBone)

iOMEDICO logo

iOMEDICO

Status

Completed

Conditions

Breast Cancer
Prostate Cancer
Bone Metastases

Study type

Observational

Funder types

Industry

Identifiers

NCT02410044
IOM - 11279

Details and patient eligibility

About

Evaluation of patient reported outcomes (PRO) / QoL regarding typical ailments in real-life patients with bone metastases treated with osteoprotective agents.

Full description

The PRO Bone project will recruit a representative cohort of patients with breast or prostate cancer suffering from bone metastases. The aim of this study is to collect data on Patient Reported Outcomes (PRO)/Quality of Life regarding bone pain and the impact of bone pain on quality of life and daily activities. PROs are assessed by a questionnaire consisting of a visual analog scale for bone pain, two questions regarding bone pain management, the bone pain module of FACT questionnaire (FACT-BP) and four questions addressing the impact of treatment on daily life (overall, social life, ability to work and ability to perform routine tasks)

Enrollment

500 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Histologically confirmed metastatic breast or prostate cancer
  • Start of first systemic osteoprotective treatment
  • Ability to read and understand German
  • Written informed consent

Exclusion criteria

• None

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems